Result of General Meeting
RNS Number : 8835PSabien Technology Group PLC22 February 2021
22 February 2021
Sabien Technology Group plc
(“Sabien” or the “Company”)
Result of General Meeting
Total Voting Rights
The Board of Sabien is announces that at its General Meeting held earlier today, all resolutions were duly passed. As a result, the 418,604,651 Placing Shares and 2,500,000,000 ordinary shares being issued pursuant to the conversion of the CULs, as announced on 3 February 2021, are expected to be admitted to trading on AIM on or around 24 February 2021 (“Admission”).
The proxy voting results of the resolutions proposed at the General Meeting are copied below:
| Resolution | Votes For* | % of votes cast | Votes Against | % of votes cast | Votes Withheld** | Total votes cast** |
| Ordinary resolution | ||||||
| 1. To authorise the issue of new ordinary shares | 171,989,541 | 78.68% | 46,594,657 | 21.32% | 1,840,207 | 218,584,198 |
| Special resolution | ||||||
| 2. To disapply pre-emption rights in relation to the allotment of new ordinary shares | 172,333,808 | 78.84% | 46,248,928 | 21.16% | 1,841,669 | 218,582,736 |
**Votes “For” include votes giving the Chairman discretion.
**”Votes Withheld” are not votes in law and do not count in the number of votes counted for or against a resolution.
Total Voting Rights
Following Admission, the Company will have 4,372,277,808 ordinary shares of 0.01p each in issue, each with one voting right. There are no shares held in treasury. Therefore, the Company’s total number of ordinary shares and voting rights is 4,372,277,808.
The above figure of 4,372,277,808 may be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.
Defined terms used in this announcement shall have the same meaning as in the announcement of 3 February 2021 unless otherwise defined herein.
| For Further Information:Sabien Technology Group plcRichard Parris, Executive Chairman | +44 20 7993 3700 |
| Allenby Capital Limited (Nominated Adviser)John Depasquale / Asha Chotai | +44 203 328 5656 |
| Peterhouse Capital Limited (Broker) Duncan Vasey / Lucy Williams | +44 207 469 0930 |
| The person who arranged for the release of this announcement on behalf of the Company was Richard Parris, Executive Chairman. A copy of this announcement will be available from the Company’s website at www.sabien.com . |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END
